Assessment study on validity of the Intervention Therapies for coronary artery disease in Japa
Not Applicable
- Conditions
- Coronary artery disease
- Registration Number
- JPRN-UMIN000000779
- Lead Sponsor
- ational Hospital Organization
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 3000
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with acute myocardial infarction treated by only thrombolytic therapy. 2.Under 20 years old.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Symptoms at firstyear,second year and third year follow-up.
- Secondary Outcome Measures
Name Time Method Incidence of Major Adverse Cardiac Evevts at first year,second year and third year follow-up.
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie intervention therapies for coronary artery disease in the AVIT-J observational study?
How do intervention therapies in AVIT-J compare to standard-of-care treatments for coronary artery disease in Japan?
What biomarkers are associated with patient selection and response prediction in AVIT-J coronary artery disease therapies?
What adverse events were observed in AVIT-J and how were they managed in coronary artery disease patients?
What combination approaches or competitor drugs are relevant to AVIT-J's observational study on coronary artery disease therapies?